pLV-tetO-myc T58A Citations (3)

Originally described in: Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse.
Stadtfeld M, Maherali N, Breault DT, Hochedlinger K Cell Stem Cell. 2008 Mar 6. 2(3):230-40. PubMed Journal

---

Articles Citing pLV-tetO-myc T58A

Articles
Blocking EGFR palmitoylation suppresses PI3K signaling and mutant KRAS lung tumorigenesis. Kharbanda A, Walter DM, Gudiel AA, Schek N, Feldser DM, Witze ES. Sci Signal. 2020 Mar 3;13(621). pii: 13/621/eaax2364. doi: 10.1126/scisignal.aax2364. PubMed
Irreversible cell cycle exit associated with senescence is mediated by constitutive MYC degradation. Afifi MM, Crncec A, Cornwell JA, Cataisson C, Paul D, Ghorab LM, Hernandez MO, Wong M, Kedei N, Cappell SD. Cell Rep. 2023 Sep 26;42(9):113079. doi: 10.1016/j.celrep.2023.113079. Epub 2023 Aug 31. PubMed
FORMATION OF MALIGNANT, METASTATIC SMALL CELL LUNG CANCERS THROUGH OVERPRODUCTION OF cMYC PROTEIN IN TP53 AND RB1 DEPLETED PULMONARY NEUROENDOCRINE CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS. Chen HJ, Gardner EE, Shah Y, Zhang K, Thakur A, Zhang C, Elemento O, Varmus H. bioRxiv [Preprint]. 2023 Oct 9:2023.10.06.561244. doi: 10.1101/2023.10.06.561244. PubMed

If you have published an article using this material, please email us at to have your article added to this page.